Heska

Heska EBIT per Share

Delisted

The EBIT per Share of Heska (HSKA) as of Nov 1, 2026 is -2.12 USD. In the previous year, EBIT per Share was -0.10 USD — a change of 2,037.06% (lower).

EBIT per Share

-2.12USD

YoY

2,037.06%

Last updated:

EBIT per Share of Heska is 2022 -2.12 USD. EBIT per Share of Heska was 2021 -0.10 USD. It decreases by 2,037.06% lower compared to the previous year.

The Heska EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023 (e)
-0.88 USD
Jan 1, 2024 (e)
0.30 USD
Jan 1, 2025 (e)
2.36 USD
Jan 1, 2026 (e)
0.56 USD
Jan 1, 2027 (e)
1.06 USD
Jan 1, 2028 (e)
1.60 USD
Jan 1, 2029 (e)
2.11 USD
Jan 1, 2030 (e)
2.66 USD
The Heska EBIT per Share history
YEAREBIT per ShareYoY
est2.66USD+26.09%
est2.11USD+31.85%
est1.60USD+50.96%
est1.06USD+89.09%
est0.56USD-76.26%
est2.36USD+681.06%
est0.30USD-134.36%
est-0.88USD-58.50%
-2.12USD+2,037.06%
-0.10USD-89.09%
-0.91USD+38.84%
-0.66USD+554.75%
-0.10USD-104.38%
2.29USD-3.16%
2.36USD+93.21%
1.22USD+151.96%
0.49USD-303.57%
-0.24USD-155.22%
0.43USD-33.58%
0.65USD+807.54%
0.07USD-91.15%
0.81USD-713.71%
-0.13USD-113.25%
0.99USD+71.21%
0.58USD+236.41%
0.17USD-119.97%
-0.86USD+30.27%
-0.66USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Heska Stock analysis

What does Heska do? Heska Corp was founded in 2001 and has since become a leading company in the field of animal health. The company is headquartered in Loveland, Colorado and has locations in the USA, Europe, and Asia. Heska's business model is based on the development, manufacturing, and marketing of innovative diagnostic and therapeutic products for animals. The company aims to provide veterinarians and pet owners with a comprehensive range of solutions to support the health and well-being of animals. Heska has divided itself into three main divisions in order to cover the entire spectrum of animal health: diagnosis, therapy, and traceability. In the "diagnosis" division, Heska offers a wide range of diagnostic test kits for various animals, including dogs, cats, horses, cattle, and pigs. The tests include blood tests, urine tests, imaging tests, and molecular diagnostics. Heska's therapy division includes products for the treatment of animals, including medications, vaccines, and pet conditioners. The company also develops innovative therapy approaches to combat diseases in animals, including oncology. Another important aspect of Heska's business model is offering targeted solutions for seamless traceability of animals for agricultural and veterinary purposes. The company offers a wide selection of animal identification products that are known for their reliability and safety. Heska is committed to continuously improving and innovating its products to help animals and pet owners worldwide. The company aims to achieve better access to healthcare for animals through its research and development in the field of animal health, thus improving the lives of all animals. In summary, Heska Corp is a significant company in the field of animal health that specializes in the development and marketing of diagnostic and therapeutic products for animals. The company's products are valued by veterinarians and pet owners worldwide and contribute to improving the health and well-being of animals. Heska is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Heska stock

EBIT per Share of Heska is -2.12 USD in 2022.

EBIT per Share of Heska changed from -0.10 USD to -2.12 USD, representing a 2,037.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Heska since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Heska

All Key Metrics — Heska